| Dr Ronald C Walpert Ii, MD | |
|
1230 Baxter St, Athens, GA 30606 | |
| (706) 548-7581 | |
| Not Available |
| Full Name | Dr Ronald C Walpert Ii |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 1230 Baxter St, Athens, Georgia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316925654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 49257 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Athens Regional Medical Center | Athens, GA | Hospital |
| St Mary's Hospital | Athens, GA | Hospital |
| St. Mary's Good Samaritan Hospital | Greensboro, GA | Hospital |
| Ty Cobb Regional Medical Center, Llc | Lavonia, GA | Hospital |
| Piedmont Walton Hospital | Monroe, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Athens Radiology Associates | 2860486107 | 33 |
| M And B Imaging, Pc | 1557623782 | 56 |
| Radiology Associates Of North Georgia | 2769715044 | 31 |
News Archive
Investigations into the foot and mouth outbreak in Britain points the finger of suspicion for the source of the infection to the nearby research centres.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open.
› Verified 5 days ago
| Entity Name | Athens Radiology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932189685 PECOS PAC ID: 2860486107 Enrollment ID: O20040412000230 |
News Archive
Investigations into the foot and mouth outbreak in Britain points the finger of suspicion for the source of the infection to the nearby research centres.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open.
› Verified 5 days ago
| Entity Name | Pro Radiology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164966461 PECOS PAC ID: 1052696432 Enrollment ID: O20170327002470 |
News Archive
Investigations into the foot and mouth outbreak in Britain points the finger of suspicion for the source of the infection to the nearby research centres.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open.
› Verified 5 days ago
| Entity Name | M & B Imaging, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932624723 PECOS PAC ID: 1557623782 Enrollment ID: O20180327002648 |
News Archive
Investigations into the foot and mouth outbreak in Britain points the finger of suspicion for the source of the infection to the nearby research centres.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open.
› Verified 5 days ago
| Entity Name | Synergy Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558886341 PECOS PAC ID: 2668727744 Enrollment ID: O20180613001114 |
News Archive
Investigations into the foot and mouth outbreak in Britain points the finger of suspicion for the source of the infection to the nearby research centres.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open.
› Verified 5 days ago
| Entity Name | Radiology Associates Of North Georgia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285124834 PECOS PAC ID: 2769715044 Enrollment ID: O20190603000252 |
News Archive
Investigations into the foot and mouth outbreak in Britain points the finger of suspicion for the source of the infection to the nearby research centres.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald C Walpert Ii, MD 485 Huntington Rd, #180, Athens, GA 30606 Ph: (706) 546-6841 | Dr Ronald C Walpert Ii, MD 1230 Baxter St, Athens, GA 30606 Ph: (706) 548-7581 |
News Archive
Investigations into the foot and mouth outbreak in Britain points the finger of suspicion for the source of the infection to the nearby research centres.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Most "locked-in syndrome" patients say they are happy, and many of the factors reported by those who say they are unhappy can be improved, suggest the results of the largest survey of its kind, published in the launch issue of the new online journal BMJ Open.
› Verified 5 days ago
Dr. William Herrington, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-548-7581 | |
Dr. Andrew J Greenshields, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-7000 | |
Dr. Russell Walker Hinerman, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 220 Hawthorne Park, Athens, GA 30606 Phone: 706-548-0500 Fax: 706-548-3575 | |
Dr. Robert Rhodes Iii, MD Radiology Medicare: Medicare Enrolled Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-548-7581 | |
Dr. Steve Bramlet, MD Radiology Medicare: Medicare Enrolled Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-548-7581 | |
Dr. Clifford Randy Smith, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1230 Baxter St, Athens, GA 30606 Phone: 706-548-7581 |